Protocadherin-1 polymorphisms are associated with eczema in two Dutch birth cohorts

Pediatric Allergy and Immunology

Volumn 23, Issue 3, 2012, Pages 270-277

  Koning, Henk ^a,b   Postma, Dirkje S ^b   Brunekreef, Bert ^c,d   Duiverman, Eric J ^a   Smit, Henriette A ^d   Thijs, Carel ^e   Penders, John ^e   Kerkhof, Marjan ^b   Koppelman, Gerard H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Asthma; Birth cohort; Eczema; Polymorphism; Protocadherin 1

Indexed keywords

ANTIASTHMATIC AGENT; CADHERIN; IMMUNOGLOBULIN E; PROTOCADHERIN 1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BLOOD SAMPLING; BREAST FEEDING; CHILD; COHORT ANALYSIS; DYSPNEA; ENVIRONMENTAL EXPOSURE; EXON; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE DELETION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; QUESTIONNAIRE; SCHOOL CHILD; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM; WHEEZING;

ASTHMA; CADHERINS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ECZEMA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MALE; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859855107     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2011.01201.x     Document Type: Article

References (34)

1. Pearce N, Ait-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007: 62: 758-66.
2. Koppelman GH. Gene by environment interaction in asthma. Curr Allergy Asthma Rep 2006: 6: 103-11.
3. Burgess JA, Dharmage SC, Byrnes GB, et al. Childhood eczema and asthma incidence and persistence: a cohort study from childhood to middle age. J Allergy Clin Immunol 2008: 122: 280-5.
4. Porsbjerg C, Von Linstow ML, Ulrik CS, et al. Risk factors for onset of asthma: a 12-year prospective follow-up study. Chest 2006: 129: 309-16.
5. Van Beijsterveldt CE, Boomsma DI. Genetics of parentally reported asthma, eczema and rhinitis in 5-yr-old twins. Eur Respir J 2007: 29: 516-21.
6. Beyer K, Nickel R, Freidhoff L, et al. Association and linkage of atopic dermatitis with chromosome 13q12-14 and 5q31-33 markers. J Invest Dermatol 2000: 115: 906-8.
7. Forrest S, Dunn K, Elliott K, et al. Identifying genes predisposing to atopic eczema. J Allergy Clin Immunol 1999: 104: 1066-70.
8. Doull IJ, Lawrence S, Watson M, et al. Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996:153(4 Pt 1):1280-4.
9. Holloway JW, Lonjou C, Beghe B, et al. Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families. Genes Immun 2001: 2: 20-4.
10. Postma DS, Bleecker ER, Amelung PJ, et al. Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995: 333: 894-900.
11. Koppelman GH, Meyers DA, Howard TD, et al. Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med 2009: 180: 929-35.
12. Redies C, Vanhalst K, Roy F. delta-Protocadherins: unique structures and functions. Cell Mol Life Sci 2005: 62: 2840-52.
13. Sano K, Tanihara H, Heimark RL, et al. Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J 1993: 12: 2249-56.
14. Fitsialos G, Chassot AA, Turchi L, et al. Transcriptional signature of epidermal keratinocytes subjected to in vitro scratch wounding reveals selective roles for ERK1/2, p38, and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem 2007: 282: 15090-102.
15. Nonnenmacher M, Salmon J, Jacob Y, et al. Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis. J Virol 2006: 80: 4890-900.
16. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007: 39: 650-4.
17. Brunekreef B, Smit J, De Jongste J, et al. The prevention and incidence of asthma and mite allergy (PIAMA) birth cohort study: design and first results. Pediatr Allergy Immunol 2002: 13 (Suppl 15): 55-60.
18. Lakwijk N, Van Strien RT, Doekes G, et al. Validation of a screening questionnaire for atopy with serum IgE tests in a population of pregnant Dutch women. Clin Exp Allergy 1998: 28: 454-8.
19. Kummeling I, Thijs C, Penders J, et al. Etiology of atopy in infancy: the KOALA Birth Cohort Study. Pediatr Allergy Immunol 2005: 16: 679-84.
20. Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994: 131: 383-96.
21. Williams HC, Burney PG, Strachan D, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994: 131: 397-405.
22. Williams HC, Burney PG, Pembroke AC, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994: 131: 406-16.
23. Kerkhof M, Koopman LP, Van Strien RT, et al. Risk factors for atopic dermatitis in infants at high risk of allergy: the PIAMA study. Clin Exp Allergy 2003: 33: 1336-41.
24. Snijders BEP, Stelma FF, Reijmerink NE, et al. CD14 polymorphisms in mother and infant, soluble CD14 in breast milk and atopy development in the infant (KOALA Study). Pediatr Allergy Immunol 2010: 21: 541-9.
25. Kerkhof M, Postma DS, Brunekreef B, et al. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax 2010: 65: 690-7.
26. Reijmerink NE, Kerkhof M, Koppelman GH, et al. Smoke exposure interacts with ADAM33 polymorphisms in the development of lung function and hyperresponsiveness. Allergy 2009: 64: 898-904.
27. Bottema RW, Reijmerink NE, Kerkhof M, et al. Interleukin 13, CD14, pet and tobacco smoke influence atopy in three Dutch cohorts: the allergenic study. Eur Respir J 2008: 32: 593-602.
28. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004: 4: 978-88.
29. Chen H, Commen JEA, Haines RL, et al. Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br J Dermatol 2011: 165: 106-114.
30. Cascella R, Cuzzola VF, Lepre T, et al. Full sequencing of the FLG gene in Italian patients with atopic eczema: evidence of new mutations, but lack of an association. J Invest Dermatol 2011: 131: 982-4.
31. Schuttelaar ML, Kerkhof M, Jonkman MF, et al. Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy 2009: 64: 1758-65.
32. Stemmler S, Parwez Q, Petrasch-Parwez E, et al. Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 2007: 127: 722-4.
33. Weidinger S, O'Sullivan M, Illig T, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008: 121: 1203-9.
34. Bønnelykke K, Pipper CB, Tavendale R, et al. Filaggrin gene variants and atopic diseases in early childhood assessed longitudinally from birth. Pediatr Allergy Immunol 2010: 21: 954-61.